Daily ROX index can predict transitioning to mechanical ventilation within the next 24 h in COVID-19 patients on HFNC - 20/10/23
Abstract |
Introduction |
High flow nasal cannula (HFNC) is used to prevent invasive ventilation in COVID-19-associated hypoxemia. The respiratory rate‑oxygenation (ROX) index has been reported to predict failure of HFNC in patients with COVID-19 pneumonia during the intensive care unit stay when measured in first hours of therapy. However, the clinical course of ICU patients may change substantially in the first days of admission. The objective of this study was to investigate whether ROX index obtained in the first four days of ICU admission could predict the need for invasive respiratory support within the next 24 h of measurements.
Methods |
A retrospective cross-sectional study was performed using a database that included adult patients with COVID-19 pneumonia treated in the ICU. Patients were followed from ICU admission and ROX index was calculated daily on HFNC. Receiver operating characteristics curves (ROCs) were performed.
Results |
Two hundred forty-nine patients were enrolled, 48% of whom require mechanical ventilation (MV). The area under the ROC of the pooled 4-day values of the ROX index as a predictor of transition from HFNC to MV within 24 h of measurements was 0.86 (95%CI 0.83 to 0.88, P < 0.001) with a cutoff point of 4.06.
Conclusion |
In COVID-19 patients in high flow nasal cannula, daily ROX index measurements successfully predicted transition to mechanical ventilation within the next 24 h.
Le texte complet de cet article est disponible en PDF.Keywords : High flow nasal cannula, Non-invasive ventilation, ROX index, COVID-19, Hypoxemic respiratory failure, Pneumonia
Abbreviations : HFNC, MV, ROX, SpO2, FiO2, RR, ROC, COPD, CKD, SAPS-3, LOS, AUROC
Plan
☆ | The study was performed in the Intensive Care Unit of Hospital Niteroi D'Or. Niteroi, Rio de Janeiro, Brazil. The authors declare that they have no competing interests and that no funding was received for the present study. |
Vol 73
P. 160-165 - novembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.